The material included in this study came from seven patients with ulcerative colitis who underwent total colectomy. The resection specimens contained 10 primary carcinomas. A total of 23 mucosal biopsies (6 rectal, 17 colonic) all taken less than 12 months before resection were available for examination.
Since the initial report in 1925' carcinoma has been recognised as an uncommon but important complication in ulcerative colitis. Warren and Sommers2 postulated a precancerous mucosal change and later, in 1967, Morson and Pang3 established the use of rectal biopsy as an aid to the early diagnosis of cancer in ulcerative colitis. The subsequent provision of both multiple rectal and colonic biopsies has led to problems of histological interpretation as actively regenerating colitic mucosa may closely resemble dysplasia.4-5 A recent international classification of the mucosal changes seen in ulcerative colitis will prove useful in assessing the risk of malignancy.6 Several additional techniques are being evaluated as diagnostic aids with varying results. These include mucin histochemistry,'8 epithelial cell kinetics,9 and flow cytometry. '0 Immunohistochemical studies have illustrated the use of tumour associated antigens, such as carcinoembryonic antigen,' " as a tissue marker for potential and established malignancy. A different approach has been to show the loss of normal cellular function Accepted for publication 18 September 1984 incurred during the evolution of malignancy. One such function is the production and secretion of IgA by the gut mucosa. Plasma cells in the lamina propria secrete IgA as a dimer linked by a joining (J) chain. Dimeric IgA is then attached to a polypeptide, secretory component (SC), manufactured in the mucosal epithelium. The assembled IgA-J-SC unit is then transported through the epithelium to the gut lumen. '2 This study concerns the immunohistochemical demonstration of carcinoembryonic antigen, secretory component, IgA, and J chain in benign and malignant mucosal changes of ulcerative colitis.
Material and methods
The material included in this study came from seven patients with ulcerative colitis who underwent total colectomy. The resection specimens contained 10 primary carcinomas. A total of 23 mucosal biopsies (6 rectal, 17 Fig. 1(a) and (b) .c E A staining (Fig. 3) , and, although usually stained at The purpose of this study was to assess the use of immunostaining for carcinoembryonic antigen and secretory component as an aid to differentiating possible functional immaturity. Secretory compo-between regenerative hyperplasia and dysplasia in nent also showed variation in glandular staining ulcerative colitis. These tissue marker antigens were sparing dysplastic crypts. Visual assessment of evaluated with reference to routine morphology immunostaining was not a sensitive enough parame-individually and in combination by use of paired secter to differentiate between low and high grades of tions. dysplasia.
In 1965 Gold and Freedman"4 showed tumour group.bmj.com on November 7, 2017 -Published by http://jcp.bmj.com/ Downloaded from specific antigens in human colonic carcinoma, and initial reports suggested that application of carcinoembryonic antigen immunostaining in tissue sections was a reliable indicator of malignant colorectal change.'5 It was thought to be of potential use in discriminating between regenerative hyperplasia and dysplasia in colitic mucosa."l Subsequently, carcinoembryonic antigen has emerged as being less specific than originally thought, showing cross reactive staining with other normal bowel constituents'3 16 and carcinoembryonic antigen related antigens." It has been shown in lung tumours," normal and malignant gall bladder epithelium,'8 and uterine cervical neoplasia."9 Several studies have noted its presence in normal2021 and inflamed2223 colorectal mucosa. This variability in staining has been attributed to differing fixation and processing techniques and specificity and titre of the primary antibody." 2021 Although fixation and processing techniques were standardised, we found a wide variation in carcinoembryonic antigen staining in this study. Carcinoembryonic antigen stained strongly in dysplastic and malignant tissues (both primary tumours and secondary deposits), although variable intensity was seen within some tumours. We could not consistently relate carcinoembryonic antigen staining to tumour differentiation. We can only agree with O'Brien et a!2' that if a tumour fails to stain with carcinoembryonic antigen it is unlikely to be colorectal in origin. Furthermore, strong carcinoembryonic antigen staining is associated with colorectal carcinoma but is not by itself a reliable indicator of malignancy. It also appears to reflect epithelial proliferation,23 as in this context carcinoembryonic antigen presence in inflamed and regenerative mucosa prevented us from using it to distinguish from areas of dysplasia.28 Future assessment using monoclonal antibody may give more well defined results.
The concept of the mucosal assembly of IgA-Jsecretory component '2 Allen, Biggart, Orchin, Foster impairment of production of secretory component or its transport through the epithelium. Presumably this functional impairment is incurred during the evolution of malignant change. In this context, Isaacson27 noted in areas of villous dysplasia that some of the superficial epithelium had normal morphological appearances but lacked secretory component, which implies a functional dysmaturity. This has been found in the present material. Thus the absence of secretory component has emerged as a potential tissue criterion for malignant change. Two studies by Isaacson27 and Rognum et a!28 have examined the effects of inflammation and dysplasia in ulcerative colitis on the tissue expression of secretory component. As in this study, they found more intense secretory component staining with differentiated tissue and lack of secretory component in dysplasia and carcinoma. In these instances the pathologist was usually in no doubt as to the absence or presence of dysplasia on routine haematoxylin and eosin assessment. It is in the borderline area of regenerative hyperplasia versus dysplasia that use of secretory component was suggested as a diagnostic aid.27 Isaacson found preservation of secretory component in regenerating mucosa and absence or reduction in dysplasia (with one exception). Rognum et alreported variable tissue antigen expression and concluded that secretory component could not be used as a discriminating factor in diagnostic work, secretory component staining being related to both the degree of dysplasia and inflammation. This study has shown more intense secretory component staining in inflamed and regenerative tissue than in dysplasia, but, also, multiple areas of similar regenerative morphology with reduction or absence of secretory component. We believe that this precludes at present the use of secretory component as a reliable diagnostic marker of early malignant change. This is particularly so when one considers that a decision for colectomy may be made on small mucosal biopsies rather than strips of mucosa.
The variation in secretory component expression in these studies is unlikely to be due to antisecretory component serum titre or specificity.27 The exact physiological relation between the production of free secretory component, its integration into assembled secretory IgA, and the IgA containing mucosal plasma cells still remains to be fully established. 2'27 Assessment of secretory component as an isolated index of epithelial maturity, particularly in inflamed regenerative mucosa, is therefore doubtful.
In conclusion, this study used an immunoperoxidase technique for carcinoembryonic antigen, IgA, and J chain in ulcerative colitis. The 
